ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Total revenue
142,312
156,473
181,157
192,925
153,612
Cost of revenue
61,689
64,550
59,828
69,133
51,821
Gross profit
80,623
91,923
121,329
123,792
101,791
Operating expenses
Research development
17,800
20,793
21,019
32,337
26,421
Selling general and administrative
102,376
120,332
127,701
148,803
107,794
Total operating expenses
134,584
154,976
161,672
197,355
149,633
Operating income or loss
-53,961
-63,053
-40,343
-73,563
-47,842
Interest expense
34,644
27,658
22,064
15,841
7,476
Total other income/expenses net
2,225
11,271
-4,535
-65,003
-4,618
Income before tax
-86,370
-79,430
-66,859
-154,179
-59,761
Income tax expense
-3,488
284
-459
498
-9,337
Income from continuing operations
-82,882
-79,714
-66,400
-154,677
-50,424
Net income
-82,882
-79,714
-66,400
-154,677
-50,424
Net income available to common shareholders
-82,882
-79,714
-66,400
-154,677
-50,424
Reported EPS
Basic
-
-9.07
-8.00
-19.10
-7.50
Diluted
-
-9.07
-8.00
-19.10
-7.50
Weighted average shares outstanding
Basic
-
8,790
8,333
8,098
6,767
Diluted
-
8,790
8,333
8,098
6,767
EBITDA
-
-43,790
-35,684
-129,189
-46,399